Hepatocellular carcinoma
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Male or female patients > 18 years and = 2.0 x 10^9/L; Hemoglobin >= 100g/L; Platelet count >= 75 x 10^9/L; Albumin >= 35 g/L ; Total bilirubin <= 34.2µmol/L(2mg/dL; Alanine transaminase (ALT) and AST <= 3.0 x upper limit of normal; Serum creatinine <= 1.5 x the upper limit of normal; Prothrombin time (PT)-international normalized ratio (INR)<= 2.2 or PT <= 4 seconds above control; 9) Patients are fully informed of the study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients with severe impairment of heart, brain, lung, kidney and other important organ functions, severe infection or other serious concomitant diseases, and that are unable to tolerate hepatectomy or TACE; 2) Patients with a history of other tumors; 3) Patients with a history of allergy to related drugs; 4) Patients with a history of organ transplantation; 5) Patients who have received treatment for tumor (including interferon); 6) People with HIV infection, drug taking or drug abusers; 7) Patients who had gastrointestinal hemorrhage or cardio cerebrovascular events within 30 days before treatment; 8) Pregnant or lactating women, or women of childbearing age who are unwilling to take contraceptive measures; 9) Patients with mental illness who can't receive informed consent or influence the treatment; 10) Other factors that may affect the enrollment and evaluation of results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease-free survival;Time to progress;Recurrence;Type of recurrence; | — |
Countries
China
Contacts
Public ContactChong Zhong
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed